Chronic myeloid leukemia (CML): prognostic factors and survival analysis
São Paulo med. j
;
114(1): 1083-1090, Jan.-Feb. 1996. tab, graf
Artículo
en Inglés
| LILACS
| ID: lil-173538
ABSTRACT
The prognostic value of different factors upon diagnosis of CML was analysed in 45 Philadelphia (Ph1)-positive patients. The median survival was 48 months. Univariate analysis showed 5 poor prognostic factors (male sex, under 45 years-old, bone marrow blasts greater than or equal to 10 percent, blood basophils greater than or equal to 6 percent and blood eosinophilis greater than or equal to 6 percent) which provided for the development of a clinical staging system Stage I whith none or one factor and a two-year survival rate of 100 percent; Stage II with two or three factors and two-year survival of 72.2 percent; and Stage III with four or five factors and two-year survival of 0 percent (p=0.00016). Multivariate survival analysis showed that combination of blood basophilia and bone marrow blasts had the strongest predective relationship to survival time. We conclude that a combination of pretreatment factors identifies different risk subcategories in CML patients and is helpful in assessing the overall prognosis and the treatment approach.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Basófilos
/
Médula Ósea
/
Leucemia Mielógena Crónica BCR-ABL Positiva
/
Eosinófilos
Tipo de estudio:
Estudio de etiología
/
Estudio observacional
/
Estudio pronóstico
/
Factores de riesgo
Límite:
Adolescente
/
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
São Paulo med. j
Asunto de la revista:
Cirurgia Geral
/
Cincia
/
Ginecologia
/
Medicina
/
Medicina Interna
/
Obstetr¡cia
/
Pediatria
/
Sa£de Mental
/
Sa£de P£blica
Año:
1996
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS